Condition

Infiltrating Urothelial Carcinoma (1)

KRAS Gene Mutation (1)

Overall Status

Completed (1)

Sign in for free

Phase

phase 3 (1)

Sponsor

UNICANCER (1)

Collaborator

Intervention

chemotherapy (1)

panitumumab (1)

Study Documents

Intervention Type

drug (1)

Funder Type

Other (1)

Study Type

Interventional (1)

infiltrating urothelial carcinoma

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Infiltrating Urothelial Carcinoma, KRAS Gene Mutation Trial in France (Chemotherapy, Panitumumab)

Completed

Infiltrating Urothelial Carcinoma
KRAS Gene Mutation

Bordeaux, France
+16 more

Mar 4, 2021